$232 Million is the total value of HARBOURVEST PARTNERS LLC's 23 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 72.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| W | Sell | Wayfair, Inc. | $133,706,000 | -7.2% | 1,739,153 | -51.1% | 57.56% | -28.6% |
| IBTX | New | Independent Bank Group, Inc. | $44,821,000 | – | 753,300 | +100.0% | 19.29% | – |
| FNJN | Finjan Holdings, Inc. | $14,115,000 | +88.9% | 4,303,435 | 0.0% | 6.08% | +45.4% | |
| LC | LendingClub Corp. | $10,470,000 | +0.4% | 1,900,206 | 0.0% | 4.51% | -22.8% | |
| BOX | Buy | Box, Inc. | $7,527,000 | +282.1% | 412,655 | +241.6% | 3.24% | +194.0% |
| PRTS | New | U.S. Auto Parts Network, Inc. | $4,770,000 | – | 1,476,877 | +100.0% | 2.05% | – |
| GBT | New | Global Blood Therapeutics, Inc. | $3,306,000 | – | 120,878 | +100.0% | 1.42% | – |
| PTI | Proteostasis Therapeutics, Inc. | $2,062,000 | -40.2% | 440,627 | 0.0% | 0.89% | -53.9% | |
| CLVS | New | Clovis Oncology, Inc. | $2,007,000 | – | 21,437 | +100.0% | 0.86% | – |
| XLRN | Acceleron Pharma, Inc. | $1,559,000 | +14.8% | 51,296 | 0.0% | 0.67% | -11.7% | |
| ZEN | New | Zendesk, Inc. | $1,535,000 | – | 55,257 | +100.0% | 0.66% | – |
| TSLA | Tesla, Inc. | $1,148,000 | +29.9% | 3,175 | 0.0% | 0.49% | 0.0% | |
| EDIT | New | Editas Medicine, Inc. | $994,000 | – | 59,227 | +100.0% | 0.43% | – |
| CTMX | Buy | CytomX Therpeutics, Inc. | $608,000 | +40.7% | 39,199 | +56.8% | 0.26% | +8.3% |
| MYOK | Sell | MyoKardia, Inc. | $578,000 | -54.0% | 44,145 | -53.8% | 0.25% | -64.5% |
| TRVN | Trevena, Inc. | $538,000 | -37.3% | 233,850 | 0.0% | 0.23% | -51.7% | |
| CPSI | New | Computer Programs & Systems, Inc. | $527,000 | – | 16,082 | +100.0% | 0.23% | – |
| GRPN | Groupon, Inc. | $523,000 | -2.4% | 136,320 | 0.0% | 0.22% | -25.0% | |
| SENS | Senseonics Holdings, Inc. | $473,000 | +0.6% | 262,588 | 0.0% | 0.20% | -22.4% | |
| YUMA | Sell | YUMA Energy, Inc. | $429,000 | -65.9% | 461,704 | -14.1% | 0.18% | -73.7% |
| VYGR | New | Voyager Therapeutics, Inc. | $400,000 | – | 44,606 | +100.0% | 0.17% | – |
| ATRA | Atara Biotherapeutics, Inc. | $148,000 | -31.8% | 10,543 | 0.0% | 0.06% | -47.1% | |
| SSNI | New | Silver Springs Network, Inc. | $60,000 | – | 5,320 | +100.0% | 0.03% | – |
| APTI | Exit | Apptio, Inc. | $0 | – | -27,551 | -100.0% | -0.18% | – |
| QTWO | Exit | Q2 Holdings, Inc. | $0 | – | -9,381 | -100.0% | -0.18% | – |
| TWLO | Exit | Twilio, Inc. | $0 | – | -13,161 | -100.0% | -0.21% | – |
| NTNX | Exit | Nutanix, Inc. | $0 | – | -165,356 | -100.0% | -1.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
| Trevena, Inc. | 25 | Q4 2021 | 1.2% |
| Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
| Zuora, Inc. | 21 | Q3 2023 | 3.4% |
| Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
| CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
| LendingClub Corp. | 18 | Q3 2019 | 11.9% |
| Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
| Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
| Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
| N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
| OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
| Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
| ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
| NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
| CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
| VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-26 |
| 13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.